Compare NSRX & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSRX | PXLW |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 39.9M |
| IPO Year | 2024 | 2000 |
| Metric | NSRX | PXLW |
|---|---|---|
| Price | $4.10 | $6.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $19.67 | $14.33 |
| AVG Volume (30 Days) | 12.3K | ★ 35.9K |
| Earning Date | 03-25-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 12.07 |
| Revenue | N/A | ★ $693,000.00 |
| Revenue This Year | N/A | $47.19 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | ★ N/A | $0.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.98 | $4.84 |
| 52 Week High | $9.50 | $15.42 |
| Indicator | NSRX | PXLW |
|---|---|---|
| Relative Strength Index (RSI) | 64.61 | 59.41 |
| Support Level | $2.90 | $5.65 |
| Resistance Level | $4.49 | $7.18 |
| Average True Range (ATR) | 0.28 | 0.41 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 89.52 | 79.25 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.